Related references
Note: Only part of the references are listed.Frequency and predictors of a high clinical response in patients with psoriasis on biological therapy in daily practice: results from the prospective, multicenter BioCAPTURE cohort
J. Zweegers et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis
Zarif K. Jabbar-Lopez et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
'New to me': changing patient understanding of psoriasis and identifying mechanisms of change. The Pso Well® patient materials mixed-methods feasibility study
P. A. Nelson et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
Comparative effectiveness of biological therapies on improvements in quality of life in patients with psoriasis
I. Y. K. Iskandar et al.
BRITISH JOURNAL OF DERMATOLOGY (2017)
'I should have taken that further' - missed opportunities during cardiovascular risk assessment in patients with psoriasis in UK primary care settings: a mixed-methods study
Pauline A. Nelson et al.
HEALTH EXPECTATIONS (2016)
Development of clinical prediction models for good or bad response to classic systemic drugs, anti-TNFs, and ustekinumab in psoriasis, based on the BIOBADADERM cohort
Ignacio Garcia-Doval et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2016)
Factors predicting pain and early discontinuation of tumour necrosis factor α-inhibitors in people with rheumatoid arthritis: results from the British society for rheumatology biologics register
Daniel F. McWilliams et al.
BMC MUSCULOSKELETAL DISORDERS (2016)
Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis
Solveig K. Sieberts et al.
NATURE COMMUNICATIONS (2016)
Demographics and disease characteristics of patients with psoriasis enrolled in the British Association of Dermatologists Biologic Interventions Register
I. Y. K. Iskandar et al.
BRITISH JOURNAL OF DERMATOLOGY (2015)
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)
Richard B. Warren et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study
Vito Di Lernia et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2014)
Some clinical factors affecting quality of the response to ustekinumab for psoriasis
Yoshinori Umezawa et al.
JOURNAL OF DERMATOLOGY (2014)
Heterogeneity of Response to Biologic Treatment: Perspective for Psoriasis
Emily Edson-Heredia et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives
A. D. Burden et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study
Stefan Kleinert et al.
RHEUMATOLOGY INTERNATIONAL (2012)
Body mass index influences the response to infliximab in ankylosing spondylitis
Sebastien Ottaviani et al.
ARTHRITIS RESEARCH & THERAPY (2012)
Adalimumab for Treatment of Moderate to Severe Chronic Plaque Psoriasis of the Hands and Feet Efficacy and Safety Results From REACH, a Randomized, Placebo-Controlled, Double-blind Trial
Craig Leonardi et al.
ARCHIVES OF DERMATOLOGY (2011)
Adverse Drug Reactions in Hospital In-Patients: A Prospective Analysis of 3695 Patient-Episodes
Emma C. Davies et al.
PLOS ONE (2009)
Predictors of response to anti-TNF-α therapy among patients with rheumatoid arthritis:: results from the British Society for Rheumatology Biologics Register
K. L. Hyrich et al.
RHEUMATOLOGY (2006)
The use of weights to account for non-response and drop-out
M Höfler et al.
SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY (2005)
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients
M Pirmohamed et al.
BMJ-BRITISH MEDICAL JOURNAL (2004)
An analysis of factors influencing short-term and sustained response to infliximab treatment for Crohn's disease
IDR Arnott et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2003)
Predictors of response to infliximab in patients with Crohn's disease
MA Parsi et al.
GASTROENTEROLOGY (2002)
Share Paper
